Plenco 548-110

Product Description

Plenco 548-110 was a phenolic molding compound manufactured by Plastics Engineering Company, commonly known as Plenco, a Wisconsin-based specialty plastics manufacturer that developed a broad catalog of thermoset resin products for industrial applications. Phenolic compounds of this type — sometimes referred to as phenol-formaldehyde molding compounds — were engineered to withstand high temperatures, resist electrical conductivity, and maintain structural integrity under mechanical stress. These properties made them valuable across a range of demanding industrial environments, including electrical component manufacturing, automotive parts production, and heavy equipment fabrication.

Phenolic molding compounds like Plenco 548-110 were produced in powder or granule form and processed through compression molding, transfer molding, or injection molding techniques. The finished parts could include electrical housings, circuit breaker components, handles, knobs, valve bodies, and other formed parts where heat resistance and dimensional stability were critical performance requirements. Plenco developed numerous grades of phenolic compound, each formulated with specific fillers and reinforcing agents intended to optimize the physical and thermal characteristics of the final molded product.

During the mid-twentieth century, asbestos was among the filler materials widely used in phenolic molding compounds by various manufacturers throughout the plastics and composites industry. Asbestos fibers enhanced the heat resistance and mechanical strength of phenolic resins, making them particularly attractive for high-temperature applications. The Plenco 548-110 formulation has been identified in litigation records as a product alleged to have contained asbestos as a component of its compound formulation.

Asbestos Content

Litigation records document that Plenco 548-110 was alleged to have contained asbestos as a filler or reinforcing material within its phenolic resin matrix. Plaintiffs in asbestos-related civil litigation alleged that asbestos fibers were incorporated into the compound formulation during the manufacturing process, consistent with industry practices of the era in which such products were produced and used.

Phenolic molding compounds containing asbestos typically incorporated chrysotile or other regulated fiber types, which were blended into the resin system to improve thermal stability and mechanical performance. When mixed into a thermoset matrix, asbestos fibers were distributed throughout the compound and could be released during the manufacturing, processing, or finishing of molded parts made from the material.

Plaintiffs alleged that Plenco 548-110, like other asbestos-containing phenolic compounds of its period, presented a hazard to workers who handled the raw compound or who worked with finished parts made from it through cutting, grinding, sanding, or other machining operations. The compound’s status as an asbestos-containing material has been asserted in legal proceedings, though the specific formulation details and production timeline for Plenco 548-110 are more fully documented through litigation discovery records than through publicly available technical specifications.

How Workers Were Exposed

Industrial workers represent the primary population identified in litigation as having been exposed to asbestos through contact with Plenco 548-110 and comparable phenolic molding compounds. Exposure pathways varied depending on where in the production and use chain a worker was situated.

Compounding and mixing operations presented one of the highest-risk exposure scenarios. Workers who handled raw phenolic compound in powder or granule form — weighing, transferring, or loading material into hoppers and molds — could disturb asbestos-containing dust and inhale airborne fibers. Phenolic compound powders are fine-particulate by nature, and any asbestos content within them could become readily airborne during routine handling.

Molding press operations involved loading compound into heated molds under pressure. Although the molding process itself encapsulated fibers within the cured resin, workers in proximity to presses could be exposed to residual dust from spilled compound, as well as fumes and particulates generated during the curing cycle.

Post-molding finishing work was a particularly significant source of fiber release. Trimming flash from molded parts, drilling, routing, sanding, or grinding finished phenolic components could fracture the resin matrix and release previously encapsulated asbestos fibers into the breathing zone of workers performing these tasks. Litigation records document that finishing operations on asbestos-containing phenolic parts were a recognized source of occupational asbestos exposure.

Maintenance and tooling workers in facilities using phenolic molding compounds were also potentially exposed through incidental contact with compound dust and machined debris that accumulated on equipment, floors, and work surfaces in molding facilities.

General industrial workers in plants where Plenco 548-110 was used — including supervisors, material handlers, quality control personnel, and housekeeping staff — may have experienced secondary or bystander exposure through shared workspaces where airborne asbestos fiber concentrations could persist beyond the immediate point of generation.

Plaintiffs alleged that adequate warnings regarding the asbestos content of these compounds and the hazards associated with their processing were not provided to workers or their employers during the relevant periods of product use. OSHA’s current permissible exposure limit (PEL) for asbestos is 0.1 fibers per cubic centimeter of air, a standard that reflects the serious occupational health risks associated with fiber inhalation. Diseases linked to asbestos exposure and documented in litigation involving industrial workers include mesothelioma, asbestosis, lung cancer, and other asbestos-related conditions, which can have latency periods of 20 to 50 years between initial exposure and clinical diagnosis.

Documented Trust Fund / Legal Options

Plenco 548-110 is classified as a Tier 2 product for the purposes of asbestos litigation, meaning that legal claims associated with this compound are pursued through the civil court system rather than through an established asbestos bankruptcy trust fund. No Plenco-specific asbestos bankruptcy trust has been identified in publicly available trust fund documentation.

Litigation records document that claims involving Plenco 548-110 and related Plenco phenolic compounds have been filed in asbestos civil litigation proceedings. Plaintiffs alleged that Plastics Engineering Company bore liability for injuries caused by asbestos-containing products it manufactured, marketed, and placed into commerce without adequate warnings or safety instructions.

Individuals who developed mesothelioma, lung cancer, asbestosis, or other documented asbestos-related diseases and who worked with or around Plenco 548-110 during their occupational history may have legal recourse through asbestos personal injury litigation. Claims may also potentially be pursued against other parties in the chain of supply, including distributors, equipment manufacturers, or employers who provided asbestos-containing materials without proper hazard communication.

Because diagnoses related to asbestos exposure often occur decades after the relevant workplace exposure, statutes of limitations for asbestos claims are typically calculated from the date of diagnosis or the date a claimant knew or reasonably should have known of the connection between their illness and asbestos exposure — not from the date of the original exposure itself. Consulting with an attorney experienced in asbestos litigation is advisable for any individual or surviving family member seeking to evaluate potential claims related to Plenco 548-110 or other Plenco phenolic molding compounds.